If you suffered losses exceeding $50,000 in TransMedics between February 23, 2023 and January 10, 2025 and would like to ...
TransMedics Group Inc (NASDAQ:TMDX) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 ...
NEW YORK, NY / ACCESS Newswire / February 26, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
Global Retirement Partners LLC increased its position in shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by ...
TransMedics Group (NASDAQ:TMDX – Get Free Report) will likely be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Beyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
SAN FRANCISCO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- A class-action lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX), a medical technology company specializing in organ transplant ...
Blade Air is seeing growth in organ logistics and air taxi services using eVTOLs. BLDE stock is a speculative buy at this ...
NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in TransMedics Group, Inc. ("TransMedics" or the "Company") (NASDAQ: TMDX) of a class action securities lawsuit.